Skip to Main Content

Jennifer Miller, PhD

Assistant Professor; Creative Director, Science for Good Initiative; Advisory Board Member, Global Healthcare Innovation Management Center, Graduate School of Business; Director, Good Pharma Scorecard Initiative; Board President, Bioethics International; Co-Director, Bioethics Masters Summer Intensive Program (with Llew Keltner); Yale Liaison, Working Group on: Bioethics of Data Science, Artificial Intelligence (AI) and Genomics Implementation Science Curriculum; Expanded Access Program for Experimental Covid19 Drugs, Ethics Committee

Contact Information

Jennifer Miller, PhD

Mailing Address

  • Yale School of Medicine

    367 Cedar Street, Harkness 4th floor

    New Haven, CT 06520

    United States

Coauthors

Selected Publications

  • Ethically Accessing Experimental Therapies for COVID-19Loike, J and Miller, J.E., (2020) Ethically Accessing Experimental Therapies for COVID-19, The Scientist.
  • Alignment of Findings in Peer-Reviewed Publications with FDA Reviews for Newly Approved Cardiovascular Disease and Diabetes Drugs, 2005-2013: A Cross-Sectional Study.Phillips, A.T., Desai, N.R., Krumholz, H.M., Zou, C.X., Miller, J.E., and Ross, J.S (under review), Alignment of Findings in Peer-Reviewed Publications with FDA Reviews for Newly Approved Cardiovascular Disease and Diabetes Drugs, 2005-2013: A Cross-Sectional Study.
  • Addressing Racial Disparities in Alpha Omega Alpha Honor Society Membership and Structural Racism in Medical EducationMiller, J.E., O'Connor, P., Boatright, D. (in revisions) Addressing Racial Disparities in Alpha Omega Alpha Honor Society Membership and Structural Racism in Medical Education, Journal of General Medicine
  • Mitochondrial Replacement Therapy, Jewish and Catholic Ethical PerspectivesLoike, J, Miller, J.E., and Tendler, M.D. (2019) Mitochondrial Replacement Therapy, Jewish and Catholic Ethical Perspectives, Studies in Judaism, Humanities, and the Social Sciences
  • Therapeutic Orphans: The Ethics of Including Children and Pregnant Women in Medical ResearchMiller, J.E. and Letendre, M.C. (2019) Therapeutic Orphans: The Ethics of Including Children and Pregnant Women in Medical Research, National Catholic Bioethics Quarterly (NCBQ)
  • Transparency and Data-sharing in Clinical Research and the Pharma IndustryMiller, J.E. (2019) Transparency and Data-sharing in Clinical Research and the Pharma Industry, Transparency in Health and Health Care in the United States, Cambridge University Press.
  • Clinical Trial Data Sharing and Results Reporting Practices Among Large Pharmaceutical CompaniesMiller, J.E., Ross, J.S., Wilenzick, M, Mello, MM. (2019) Clinical Trial Data Sharing and Results Reporting Practices Among Large Pharmaceutical Companies, BMJ;366:l4217
  • Why we need a new social contract for data in healthcareMiller, J.E. and Mills, P. (2019) Why we need a new social contract for data in healthcare, World Economic Forum.
  • Data sharing in clinical trials: Keeping score.Miller, J.E. and Price, A. (2019) Data sharing in clinical trials: Keeping score, The BMJ Opinion.
  • PUBLISHED DATABASE:Miller, J.E., Ross, J.S., Wilenzick, M, Mello, MM. (2019) Data from: Clinical Trial Data Sharing and Results Reporting Practices Among Large Pharmaceutical Companies, BMJ;366:l4217 Dryad Digital Repository https://doi.org/10.5061/dryad.k81584t.2
  • Big Data Probably Knows More About You Than Your Friends DoMiller, J.E. (2018). Big Data Probably Knows More About You Than Your Friends Do, Leaps Magazine.
  • Letter In ReplyMiller, J.E., Mello, M.M., Korn, D., Ross, J.S. (2017) Letter In Reply: Clinical Trial Transparency: A re-assessment of industry compliance with clinical trial registration and reporting requirements in the United States, BMJ Open, 7.
  • Authority and Ambiguity: The Complex History of, and Current Challenges to, U.S. Administrative Agencies’ Rulemaking PowerBenston, S., Ritcey, N., Miller, J.E. (2017). Authority and Ambiguity: The Complex History of, and Current Challenges to, U.S. Administrative Agencies’ Rulemaking Power, NYSBA Health Law Journal, 22 (2): 45-53.
  • The Hidden Costs of New Drugs: Improving FDA Evaluations Without Jeopardizing Safety and EfficacyLoike, J.D. and Miller, J.E. (2017). The Hidden Costs of New Drugs: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy, The Scientist.
  • Transparency and Trustworthiness in Healthcare InnovationMiller, J.E. (2016). Transparency and Trustworthiness in Healthcare Innovation, Healthcare Innovation, Health Policy Publishing
  • How Full Disclosure of Clinical Trial Data will Benefit the Pharmaceutical IndustryMiller, J.E. (2016). How Full Disclosure of Clinical Trial Data will Benefit the Pharmaceutical Industry, The Pharmaceutical Journal, 295 (7890)
  • Designing Clinical Trials for New DrugsMiller, J, Caplan, A., and Blasimme, A. (2016). Designing Clinical Trials for New Drugs. Clinical Researcher, 30(1), 34-39. http://dx.doi.org/10.14524/CR-15-0045.
  • Corruption and BioethicsMiller, J.E., (2015). Corruption and Bioethics, In H. ten Have (Ed), Encyclopedia of Global Bioethics, Springer.
  • Certification and Corporate ReputationMiller, J.E., (2015). Certification and Corporate Reputation. Craig Carroll (Ed.), Encyclopaedia of Corporate Reputation. Sage Publications, Inc.
  • Behavioral EconomicsMiller, J.E., Amit, E., & Posten, A.C. (2015). Behavioral Economics. In H. ten Have (Ed.), Encyclopedia of Global Bioethics (pp. 1–6). Cham, Switzerland: Springer.
  • Developing Drugs DifferentlyMiller, J.E. (2015) Developing Drugs Differently. Health Affairs, 34 (12):2202
  • Bioethical Standards in the Pharmaceutical Industry? A proposal for how to marry theory with praxis.Miller, J.E. (2015). Bioethical Standards in the Pharmaceutical Industry? A proposal for how to marry theory with praxis. IF Press, Rome, Italy.
  • Restoring Trust, Mission and Ethics in the Pharma IndustryMiller, J.E. (2015) Restoring Trust, Mission and Ethics in the Pharma Industry, BrinkNews, Atlantic Media.
  • Translational BiotechnologyLoike, J. and Miller, J.E. (2014). Translational Biotechnology. The Scientist.
  • The Ethics of Personalized MedicineMiller, J.E., & Loike, J. (2014). The Ethics of Personalized Medicine, Bioethics, 4th Edition. Edited by Bruce Jennings. Farmington Hills, MI: Macmillan Reference USA.
  • Corruption and BioethicsMiller, J.E., & English, W. (2013). Corruption and Bioethics. In B. Gordijn, & H. ten Have (Eds.), Handbook of Global Bioethics. Springer, 599-618.
  • Rebuilding Trust and Effectively Communicating Ethics EffortsMiller, J.E. (2013) Rebuilding Trust and Effectively Communicating Ethics Efforts. About Pharma and Medical Devices. di Redazione Aboutpharma Online 14 Gennaio 2013. By: Jennifer E. Miller, PhD, Edmond J. Safra Center for Ethics, Harvard University.
  • On Restoring Trust and Ethics in PharmaMiller, J.E. (2013) On Restoring Trust and Ethics in Pharma, Edmond J. Safra Center for Ethics E-Book Series, Harvard University.
  • Pfizer’s Stem Cell Ventures, Eli Lilly’s DR Payment Disclosures, & the Supreme Court Case Wyeth v. Levine’s Preemption TemptationMiller, J.E. (October 1, 2008) Pfizer’s Stem Cell Ventures, Eli Lilly’s DR Payment Disclosures, & the Supreme Court Case Wyeth v. Levine’s Preemption Temptation, Biotech-Now, Biotechnology Industry Organization, Washington, DC.
  • Globalization in BiotechnologyMiller, J.E. (June 20, 2008) Globalization in Biotechnology, Biotech-Now, Biotechnology Industry Organization, California.
  • Ernst & Young 2008 Global Biotechnology Report, Trends Summary: R&D productivity, personalized medicine and globalizationMiller, J.E. (June 19, 2008) Ernst & Young 2008 Global Biotechnology Report, Trends Summary: R&D productivity, personalized medicine and globalization, Biotech-Now, Biotechnology Industry Organization, California.